Sapitinib
- Generic Name
- Sapitinib
- Drug Type
- Small Molecule
- Chemical Formula
- C23H25ClFN5O3
- CAS Number
- 848942-61-0
- Unique Ingredient Identifier
- 3499328002
- Background
Sapitinib has been used in trials studying the treatment and basic science of Neoplasms, Breast Cancer, Breast Neoplasms, Metastatic Cancer, and Metastatic Breast Cancer, among others.
Biomarker-Driven Clinical Trial Designs: Basket, Umbrella, and Platform Trials in Precision Medicine
• Basket trials leverage drug-target relationships to extend drug indications across different tumor types, identifying effective therapies based on shared molecular targets.
• Umbrella trials validate multiple therapies for a specific disease by comprehensively profiling molecular features, enabling personalized treatment strategies based on individual subtypes.
• Platform trials, as dynamic umbrella designs, efficiently screen optimal treatments in a long-term, adaptive model, ensuring patients receive the most effective interventions based on ongoing efficacy assessments.
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath